Lexicon Pharmaceuticals, Inc. (LXRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 417.51M |
| Enterprise Value | 445.42M |
| P/E Ratio | -36.97 |
| PEG Ratio | -0.14 |
| Price/Sales Ratio | 16.84 |
| Price/Book Ratio | 5.21 |
| Enterprise/Revenue | 17.12 |
| Enterprise/EBITDA | -68.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.37 |
| Operating Margin | -0.35 |
| Return On Assets | -0.1 |
| Return On Equity | -0.19 |
| Revenue | 49.8M |
| Revenue/Share | 0.17 |
| Gross Profit | 49.53M |
| EBITDA | -41.38M |
| Net Income | -50.34M |
| Diluted EPS | -0.14 |
| Total Cash | 170.66M |
| Total Cash/Share | 0.43 |
| Total Debt | 57.71M |
| Total Debt/Equity | 0.28 |
| Current Ratio | 18.79 |
| Book Value Per Share | 0.51 |
| 52-Week Change | 179.16 |
| 52-Week High | 2.67 |
| 52-Week Low | 0.8 |
| Moving Average 50 Days | 1.98 |
| Moving Average 200 Days | 1.55 |
| Average Volume | 3.08M |
| Shares Outstanding | 444.2M |
| % Held by Institutions | 89.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | May 21, 2015 |